ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 4 filers reported holding ALKERMES PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,281,616 | -12.6% | 402,771 | -2.3% | 0.02% | -7.7% |
Q2 2023 | $12,904,678 | +12.9% | 412,290 | +1.7% | 0.03% | +4.0% |
Q1 2023 | $11,426,957 | +7.9% | 405,355 | 0.0% | 0.02% | +4.2% |
Q4 2022 | $10,591,926 | +37.3% | 405,355 | +17.4% | 0.02% | +26.3% |
Q3 2022 | $7,713,000 | -8.9% | 345,396 | +21.5% | 0.02% | -5.0% |
Q2 2022 | $8,469,000 | +937.9% | 284,280 | +817.0% | 0.02% | +900.0% |
Q1 2022 | $816,000 | +16.7% | 31,000 | +3.1% | 0.00% | +100.0% |
Q4 2021 | $699,000 | – | 30,070 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
13D Management LLC | 415,055 | $9,268,000 | 4.85% |
Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |